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ABSTRACT
Chlamydia trachomatis (Ct) is the most common cause of bacterial sexually transmitted infection and infectious cause of
blindness (trachoma) worldwide. Understanding the spatial distribution of Ct infection may enable us to identify
populations at risk and improve our understanding of Ct transmission. In this study, we sought to investigate the spatial
distribution of Ct infection and the clinical features associated with high Ct load in trachoma-endemic communities on the
Bijago´s Archipelago (Guinea Bissau). We collected 1507 conjunctival samples and corresponding detailed clinical data
during a cross-sectional population-based geospatially representative trachoma survey. We used droplet digital PCR to
estimate Ct load on conjunctival swabs. Geostatistical tools were used to investigate clustering of ocular Ct infections.
Spatial clusters (independent of age and gender) of individuals with high Ct loads were identified using local indicators of
spatial association. We did not detect clustering of individuals with low load infections. These data suggest that infections
with high bacterial load may be important in Ct transmission. These geospatial tools may be useful in the study of ocular Ct
transmission dynamics and as part of trachoma surveillance post-treatment, to identify clusters of infection and
thresholds of Ct load that may be important foci of re-emergent infection in communities.
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INTRODUCTION
Chlamydia trachomatis is the leading infectious cause of blind-
ness and the most common sexually transmitted bacterium.
Trachoma is caused by infection with ocular strains of C. tra-
chomatis and manifests as distinct clinical syndromes, begin-
ning with an acute self-limiting keratoconjunctivitis which may
progress to chronic inflammatory disease with subsequent con-
junctival scarring and blinding sequelae. A spectrum of disease
severity exists, which can be graded objectively (Dawson, Jones
and Tarizzo 1981; Thylefors et al. 1987).
The World Health Organization (WHO) advocates the imple-
mentation of the SAFE strategy (Surgery for trichiasis, Antibi-
otics for active infection, Facial cleanliness to prevent disease
transmission and Environmental improvement to increase ac-
cess to water and sanitation) for trachoma elimination. Mass
Drug Administration (MDA) of azithromycin aims to clear infec-
tion from communities such that trachoma ceases to be a public
health concern (Kuper et al. 2003).
Understanding the spatial distribution of disease and infec-
tion in trachoma-endemic regions is increasingly recognised in
national trachoma control programme planning, enabling the
identification of at-risk populations and prioritisation of target
areas for control and implementation and optimal scaling of
SAFE (Baker et al. 2010; Clements et al. 2010; Smith et al. 2011,
2013a,b). It may also be important in understanding transmis-
sion, transmission thresholds and the dynamics of spread and
recovery from infection following intervention.
Spatial analysis provides powerful methods to study the re-
lationship between active trachoma and ocular infection with
C. trachomatis. The spatial relationship between disease and in-
fection defined over space is termed spatial dependence. This
is measured as the existence of statistical association (depen-
dence) between disease and infection associated with location.
To explore spatial dependence, measures of spatial autocorre-
lation are used. Spatial autocorrelation assumes that near ob-
jects are more related than distant objects. In the context of in-
fectious diseases, this concept may be applied to explore the
relationship between infection and disease where the spatial
distribution can be used to define underlying processes such as
exposure or transmission. Spatial regressionmodels can thus be
used to understand the epidemiology of active trachoma and C.
trachomatis infection.
Global spatial autocorrelation statistics are used to describe
the overall spatial patterns in the data. Local indicators of spatial
association take actual values of observations in the context of
adjacent values allowing mapping and definition of clusters at
exact locations. This allows for the examination of small-scale
heterogeneity and identification of statistically significant clus-
ters and outliers of similar observations in space. In the context
of global spatial patterns described above, this provides us with
a greater understanding of the relationship between infection
and disease.
In this study, we applied molecular and geostatistical tools
to investigate the spatial epidemiology of C. trachomatis infec-
tion and active trachoma in a population-based study conducted
in a trachoma-hyperendemic treatment-naı¨ve population from
the Bijago´s Archipelago of Guinea Bissau in West Africa. This is
the first study to use local indicators of spatial association using
individual-level C. trachomatis load data in the context of spatial
dependence to investigate the relationship between infection
and disease. This is important in understanding the epidemi-
ology of ocular C. trachomatis infection and may inform further
studies on C. trachomatis transmission dynamics, which are fun-
damental to successful trachoma elimination and surveillance
strategies.
MATERIALS AND METHODS
Ethical approval
This study was conducted in accordance with the declaration
of Helsinki. Ethical approval was obtained from the Comiteˆ
Nacional de E´tica e Sau´de (Guinea Bissau), the LSHTM Ethics
Committee (UK) and The Gambia Government/MRC Joint Ethics
Committee (The Gambia). Written informed consent was ob-
tained from all study participants or their guardians on their
behalf if they were children. A signature or thumbprint is con-
sidered an appropriate record of consent in this setting by the
above ethical bodies. After survey completion, all communities
on the study islands were treated with a single height-based
dose of oral azithromycin in accordance withWHO and national
protocols.
Study area
The Bijago´s Archipelago has a total area of more than 10 000
km2 and lies between N 11038′19.68′′ and N 10051′40.32′′, W
16029′38.40′′ and W 15027′17.28′′. The surface area covers ∼900
km2, of which 350 km2 is mangrove forest (Van der Linde and
Dankin 1998). Maximum altitude is 50 m. The climate is hu-
mid and tropical, with a rainy season from May to November,
when average monthly rainfall is 400 mm3 (World Bank 2013).
Mean monthly temperature is 27.3◦C (25.1◦C–29.2◦C), with peak
temperatures prior to the rainy season. There are 88 islands
and islets of which ∼20 are permanently inhabited. The remain-
der are inhabited periodically for seasonal agriculture and tradi-
tional initiation ceremonies. The study was conducted on four
islands of the archipelago (Fig. 1). These four islands comprise a
total rural population of 5613 (National Population Census, 2010,
Instituto Nacional de Estatı´stica, Guine´-Bissau) and a total area
of 215 km2.
Study design and study population
Trachoma survey methodology and this study population have
been described previously (Edwards et al. 2008; Harding-Esch
et al. 2010; Roberts et al. 2013; Last et al. 2014a,b). To satisfy ade-
quate geospatial representation at village level, we included all
38 villages on the four study islands and randomly sampled one
in five households (with a minimum of five per village) from
each. All were sampled if there were fewer than six households
in the village. Small villages are thus over-represented by the
minimum sampling criteria imposed. Data were geocoded at
household and village level using the Garmin eTrex H handheld
Global Positioning Systems (GPS) unit (Garmin Ltd, UK).
Clinical examination and conjunctival sampling
A single validated examiner assessed each participant using the
WHO simplified and modified FPC grading systems (Dawson,
Jones and Tarizzo 1981; Thylefors et al. 1987). In the modified
FPC system, follicles (F), papillae (P) and conjunctival scarring
(C) are each assigned a separate grade from 0 to 3. FPC grades of
F2/3 or P3 equate to a diagnosis of active trachoma (TF (follicular
trachoma) or TI (inflammatory trachoma) by the WHO simpli-
fied system) and a grade of C2/3 (and in some cases C1) equates
to a diagnosis of TS (trachomatous scarring). A trachoma grade
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Figure 1. The Bijago´s Archipelago, Guinea Bissau ( C© Ezilon 2009). The islands of Bubaque, Canhabaque, Rubane and Soga (circled in red) were included in the current
study.
was assigned to the upper tarsal conjunctivae of each consent-
ing participant using adequate light and a ×2.5 binocular mag-
nifying loupe. Both methods were used in order that study data
should be comparable to data used by trachoma control pro-
grammes and research studies requiring detailed information
related to disease severity and have been used previously in sim-
ilar settings (Burton et al. 2003, 2006).
Samples were taken from the left upper tarsal conjunctiva of
each participant with Dacron swabs (Fisher Scientific, UK) using
a well-tolerated standardised procedure described in previous
studies (Keenan et al. 2010; Stare et al. 2011; Roberts et al. 2013;
Last et al. 2014a,b).
Detection and quantitation of Chlamydia trachomatis
ocular infection
DNA extraction and droplet digital PCR (ddPCR) (Bio-Rad Labo-
ratories, Hemel Hempstead, UK) were conducted as described
previously (Roberts et al. 2013; Last et al. 2014a,b). We used
C. trachomatis plasmid-based ddPCR to diagnose infection and
a single-copy pathogen chromosomal gene (omcB) to esti-
mate pathogen load in each plasmid-positive sample (Roberts
et al. 2013; Last et al. 2014). The plasmid-based screening
PCR included primers for human DNA (RPP30). A sample was
deemed adequate if sufficient quantities of RPP30 DNA were
present on PCR as defined previously (Roberts et al. 2013; Last
et al. 2014).
Estimated quantities of omcB (C. trachomatis load) and plas-
mid are expressed as copies/swab. This is amethod that we have
previously employed for similar analyses (Solomon et al. 2003;
Burton et al. 2003; Faal et al. 2006; Andreasen et al. 2008; Last et al.
2014; West et al. 2014). Data reported by Solomon et al. (2004)
(showing a clear reduction in C. trachomatis load and disease
severity in a trachoma-endemic community in Tanzania follow-
ingmass drug treatment with azithromycin (MDA)), and Alexan-
der et al. (2005) (showing a reduction in community C. trachomatis
load (calculated using the same method) following MDA), pro-
vide evidence that measuring C. trachomatis load as copies/swab
in this context is appropriate. We do not report C. trachomatis
load per eukaryotic cell since inflammatory cells are attracted to
the conjunctiva in the presence of ocular C. trachomatis infection
which would be included amongst sampled cells and may arte-
factually decrease the C. trachomatis load. This is of particular
concern in active trachoma, where inflammation can be intense
and result in high loads of human cellular material on a swab.
This phenomenon has also been noted in urogenital C. trachoma-
tis infection (Jalal et al. 2011).
Statistical analysis
Chlamydia trachomatis quantitation data were processed as de-
scribed previously (Roberts et al. 2013; Last et al. 2014). GPS
data were downloaded into MapSource v16.16.3 (Garmin Ltd).
All data were double entered into a customised database (Mi-
crosoft Access 2007) and discrepancies resolved through refer-
ence to source documents. Data were cleaned and analysed in
STATA 13 (Stata Corporation, College Station, TX, USA). Statisti-
cal significance was determined at the 5% level.
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Mixed effects linear regression models of Chlamydia trachomatis
load and clinical phenotype
Chlamydia trachomatis load data were log(e) transformed where
indicated. The geometric mean of load, respective standard
error (SE) and 95% confidence intervals (CI) were calculated.
An analysis of variance (ANOVA) with pairwise comparisons
was used to compare load across detailed clinical phenotypes.
Assessment of group differences and multiple comparisons
were adjusted for using the Scheffe´ correction (Ruxton and
Beauchamp 2008). Associations between load and detailed clin-
ical phenotype were examined using univariable and multivari-
ablemixed effects linear and logistic regressionmodels account-
ing for household-level clustering detected in previous studies
(Last et al. 2014).
Geostatistical analyses
Geocoded data were projected into UTM Zone 28N. ArcGIS 10.1
(ESRI Inc., USA) and the R statistical package v3.0.2 (The R Foun-
dation for Statistical Computing, http://www.r-project.org using
spdep, automap and nlme packages) were used for all geostatis-
tical analyses (Bivand 2010; Hiemstra et al. 2009; Pinheiro et al.
2014). In the following analyses, the zone of indifference is used
to define adjacency. Thismethod assumes that each observation
has local influence that decreaseswith distance beyond a critical
distance cut-off, resulting in an adapted model of impedance,
or distance decay, such that all features have an impact on all
other features, but this impact decreases with distance. The cru-
cial cut-off used in this study is derived from the distance over
which spatial autocorrelation occurs in these data and relates to
the village boundaries, assuming impedance as described above.
Previously we have shown that clustering exists at this level in
these communities (Last et al. 2014), which supports using this
threshold. This method is appropriate for point data and takes
into account the extent of spatial autocorrelation in selecting
data-driven threshold cut-offs (Chang 2010).
Spatial autocorrelation
The Moran’s I statistic was used to evaluate global spatial auto-
correlation in the distribution of the household-level prevalence
of disease and infection. The values of Moran’s I range between
–1 and +1. A value close to –1 indicates negative autocorrela-
tion (complete dispersion), while a value close to +1 indicates
positive autocorrelation (clustering) of features. A value close
to 0 suggests random arrangement. Z-scores and P-values are
assigned to ascertain whether spatial autocorrelation is statisti-
cally significant (Moran 1950). Since theMoran’s I statistic can be
sensitive to skewed distributions, a permutation test was used
to verify the results. This uses Monte Carlo simulations to gen-
erate a Moran’s I sampling distribution (Cliff and Ord 1981).
Empirical semivariograms were used to obtain the distance
range over which spatial autocorrelation occurs using the av-
erage squared distance between paired data values against the
distance (or lag) separating the pairs to estimate the spatial co-
variance structure of the data to inform the geostatistical mod-
els (Diggle, Tawn and Moyeed 1998).
Linear and logistic mixed effects regression models were
also applied to examine the effect of spatial autocorrelation on
clustering. We used the covariance structure to compare mod-
els with and without a spatial component. The log likelihood,
Akaike information criterion (AIC) and Bayesian information cri-
terion (BIC) were used to compare models (Zucchini 2000).
Local indicators of spatial association: cluster–outlier analyses
Clustering and outlier analysis was applied using the local
(Anselin) Moran’s I statistic in ArcGIS 10.1 Spatial Statistics Tool-
box (ESRI Inc., USA). The zone of indifference was used to de-
fine adjacency and the Euclidean distance thresholdwas derived
from empirical semivariograms as described above. The Eu-
clidean distance threshold was thus the distance over which the
highest positive spatial autocorrelation for C. trachomatis infec-
tion existed. Together, these account for the geography (islands
with populated (villages) and non-populated areas) (Anselin
1995). Individuals’ C. trachomatis loads were used as the variable
of interest. Since these populations and areas are small with lit-
tle ecological variation, this single threshold value is sufficient.
A positive value for I indicates that a feature has adjacent fea-
tures with similarly high or low attributable values (a cluster).
A negative value for I indicates that adjacent features have dis-
similar values and that this feature is an outlier. Cluster–outlier
analysis identifies spatial clusters of features with high or low
values and spatial outliers by calculating Moran’s I, Z-scores, P-
values and a code to represent the cluster type. Cluster types
are defined as clusters of high values (HH, high-high), clusters of
low values (defined as above) (LL, low-low), a high value outlier
surrounded by predominantly low values (HL, high-low) and a
low value outlier surrounded by predominantly high values (LH,
low-high). A group of geospatially proximal infections where the
bacterial load values are not statistically similar is defined as a
non-significant cluster.
In this analysis, ‘low’ values include both low values related
to low load infections and null (zero) values related to uninfected
individuals. To explore this, these analyses were conducted first
on the whole data set, including uninfected individuals with a
‘zero’ value for infectious load, and then on infected individuals
only.
RESULTS
Trachoma and Chlamydia trachomatis infection prevalence is hy-
perendemic in this population and is described elsewhere in de-
tail (Roberts et al. 2013; Last et al. 2014). All swab samples in the
study were positive for the presence of the human DNA target
RPP30. Chlamydia trachomatis load was skewed, with themajority
of cases having low copy numbers (<1000 copies/swab). Log-(e)
transformation removed the skew (skewness –0.106, P = 0.5454)
in these analyses.
Chlamydia trachomatis bacterial load and clinical
disease severity in individuals with Chlamydia
trachomatis infection
The geometric mean of estimated omcB copies/swab present in
clinically normal conjunctivae (F0/P0/C0) was 294 copies/swab
(95% C.I. 165–524). In clinically active trachoma, it was 8562
copies/swab (95% C.I. 5412–13546). Significantly higher loads
were detected in individuals with increasing F and P scores (Ta-
ble 1). Chlamydia trachomatis load by age and clinical phenotype is
shown in Fig. 2. The majority of infections with high loads were
in children under 10 years of age with active trachoma.
Spatial structure of active trachoma and Chlamydia
trachomatis infection
Significant positive spatial autocorrelationwas evident for C. tra-
chomatis infection (Moran’s I = 0.19, P < 0.0001) but not active
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Table 1. Estimated C. trachomatis load (omcB copies/swab) and ANOVAa by detailed clinical phenotype in infected individuals.
Clinical omcB copies/swab 95% CI P-Value
phenotype nb (geometric mean) (SE geometric mean) (ANOVA) Median Min Max
Normal (F0P0C0) 71 294 165, 524 Baseline 176 15 96333
Active trachoma (TF and/or TI) 92 8562 5412, 13546 P < 0.00001 14236 17 274835
Scarring trachoma (TS) 19 928 280, 3074 P = 0.4069 2142 17 49125
Follicular score (F)
0 91 438 251, 762 Baseline 227 15 202632
1 20 1288 448, 3697 P = 0.324 Baseline 1710 34 96333
2 27 3212 1264, 8165 P = 0.002 P = 0.624 Baseline 3203 27 140693
3 46 19870 2832, 25927 P < 0.0001 P < 0.0001 P = 0.018 22767 323 274835
Inflammatory score (P)
0 46 122 68, 218 Baseline 67 15 41059
1 70 1534 871, 2702 P < 0.0001 Baseline 1469 16 202632
2 46 10413 5461, 19857 P < 0.0001 P < 0.0001 Baseline 18569 17 274835
3 22 14053 5550, 35581 P < 0.0001 P < 0.0001 P = 0.964 21864 34 158548
Scarring score (C)
0 155 1902 1207, 2996 Baseline 2095 15 274835
1 11 449 111, 1816 P = 0.438 Baseline 204 34 11556
2 9 990 192, 5111 P = 0.927 P = 0.941 Baseline 589 76 54651
3 9 2475 253, 24192 P = 0.995 P = 0.608 P = 0.923 7023 17 49125
aScheffe´ correction used for multiple comparisons.
bn = number of individuals with quantifiable C. trachomatis bacterial load.
Figure 2. Chlamydia trachomatis load by age and clinical phenotype in infected
individuals. The y axis shows the natural logarithmic scale of C. trachomatis bac-
terial load (omcB copies/swab).
trachoma (Moran’s I = 0.07, P = 0.0659). Semivariograms demon-
strate that autocorrelation in infection is negligible in distances
greater than 1719 m (Fig. 3). We found no evidence of spatial au-
tocorrelation in the distribution of C. trachomatis load (Moran’s
I = 0.05, P = 0.4464).
Chlamydia trachomatis loadwas the strongest predictor of clin-
ically active trachoma. In accordance with the semivariograms,
including spatial structure inmultivariablemixed effects regres-
sion analyses for active trachoma and C. trachomatis infection
improves the fit of the models (Table 2).
Inflammatory and follicle scores were strongly associated
with bacterial load. Inclusion of the spatial structure in mod-
els predicting C. trachomatis load improved the fit, but the effect
of spatial dependence becomes undetectable when age and dis-
ease severity scores are included, thus resolving residual spatial
variation (Table 3).
Cluster and outlier analysis of Chlamydia trachomatis
infection
High load infections were clustered with other high load infec-
tions (HH clusters) (Fig. 4). Outliers where there was a single low
load infection amidst predominantly high load infections (HL)
were also demonstrated. There was no clustering of low load in-
fections (or zero values from uninfected individuals) (LL clus-
ters), and there were no statistically significant outlying high
loads surrounded by predominantly low loads (LH). Analyses
were conducted on the whole data set and infections only as
described above. There were no individuals with infections be-
low 10 000 omcB copies/swab noted within an HH cluster or as
an HL outlier.
DISCUSSION
The majority of ocular Chlamydia trachomatis infections occur in
children, who have the highest loads andmost severe active tra-
choma. However, infection predominantly occurs at low bacte-
rial loads in the population overall. Similar findings have been
observed in other studies (Solomon et al. 2003; Burton et al. 2006;
Faal et al. 2006), though we found a greater prevalence of infec-
tion across all age groups typical of hyperendemic settings. Al-
most half the individuals with quantifiable infection had a nor-
mal clinical phenotype, though themean C. trachomatis load was
significantly lower than in those with active trachoma, which is
consistent with other studies in meso and hyperendemic set-
tings (Solomon et al. 2003; West et al. 2005).
In this population, C. trachomatis load increases with disease
severity (for both follicular (F) and inflammatory (P) scores), the
strongest association being with increasing P-scores. The asso-
ciation between ocular C. trachomatis load and disease severity
in trachoma is supported by findings from other studies (Burton
et al. 2003, 2006; Solomon et al. 2003; Michel et al. 2011). The asso-
ciation between C. trachomatis load and high F-scores is in part
due to collinearity between F and P, where with high F-scores
there is likely to be inflammation present. Inflammation has
previously been found to be associated with high C. trachomatis
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Figure 3. Empirical semivariograms and fitted models for household prevalence of (a) ocular C. trachomatis infection, (b) active trachoma and the distribution of (c)
ocular C. trachomatis bacterial load. (a) Unadjusted household prevalence of C. trachomatis infection. (b) Household prevalence of active trachoma in 1–9 year olds. (c)
Ocular C. trachomatis bacterial load. Prevalence data were log transformed (ln(ln+1)) due to significant negative skew. Active trachoma is defined by TF/TI by the WHO
Simplified Grading System (Thylefors et al. 1987) (F2/F3 or P3 by the Modified FPC Grading System; Dawson, Jones and Tarizzo 1981). Distance is indicated in metres.
Model fit with the smallest residual sum of squares (Matern, M. Stein’s Parameterization (Ste)). All values of Kappa (smoothing parameter of the Matern model) tested.
Nugget, sill, range and Kappa are all estimated from the data.
Table 2. Multivariable mixed effects logistic regression analysis
showing the effect of spatial dependence on clinically active tra-
choma and ocular C. trachomatis infection.
Model Predictor variables n AICa
C. trachomatis infection
No spatialb Age 1426 854.8
Spatialc 801.8
No spatial Age 1426 546.4
Spatial Active trachomad 163 495.6
Active trachoma
No spatial Age 1426 697.9
Spatial 659.0
No spatial Age 1426 389.5
Spatial C. trachomatis infection 224 362.3
No spatial Age 1426 251.2
Spatial C. trachomatis loade 180 232.7
aAIC = Akaike information criterion.
bWith household or village as cluster variables.
cIncluding of spatial structure.
dDefined as TF/TI using the WHO simplified grading system (Thylefors et al.
1987).
eDefined as log-(e) omcB copies/swab.
loads and persistence of infection in children (Bobo et al. 1997).
This is consistent with the high prevalence of infection and the
spectrum of load and phenotype observed in this age group
but may also be associated with pathogen virulence if there
are different C. trachomatis strains in circulation. Further anal-
ysis is underway to investigate associations between pathogen
genotype, clinical phenotype and geospatial clustering of
strains.
There is spatial dependence in the distribution of C. tra-
chomatis infection, demonstrated by positive spatial autocorre-
lation. The distance over which this occurs (1719 m) equates
to that of village boundaries. We used this data-driven thresh-
old in our geostatistical models to account for the diffi-
culties in performing this type of analysis in small island
populations.
Our data show that the highest burden of infection (and load)
is in children under 10 years of age. There are usually only
one or two children of this age group within a household in
these communities (Last et al. 2014). The high load clusters (HH)
and high load outliers (HL) are geographically close to the non-
significant clusters and both exist within the village boundaries
in this study (<200 m apart). These data support the hypothe-
sis that transmission occurs at village level in this population.
Spread from an individual within an HH cluster to an individ-
ual in a non-significant cluster is also possible and requires fur-
ther investigation in longitudinal and mathematical modelling
studies.
Although household and village-level clustering is evident in
active trachoma and ocular C. trachomatis infection (Bailey et al.
1989; Blake et al. 2009; Hagi et al. 2010; Last et al. 2014), the in-
clusion of this spatial structure in regression models for active
trachoma and C. trachomatis infection further improves model
fit and demonstrates underlying spatial processes in the rela-
tionship between infection and disease, such that cases of ac-
tive trachoma may represent recent exposure to C. trachoma-
tis infection. The effect of spatial dependence in infection is
greater than in active trachoma, perhaps reflecting the complex-
ity of the disease process, where host–pathogen interactions
contribute.
There was no global spatial autocorrelation evident for C.
trachomatis bacterial load, likely reflecting the stronger influ-
ence of underlying social and biological rather than spatial pro-
cesses. However, we were able to use local indicators of spa-
tial association to examine fine-scale spatial clustering to iden-
tify clustering of high load infections. Spatial clusters, inde-
pendent of age and gender, of individual infections with high
bacterial loads (HH) and high load outliers that cluster with
other low loads (HL) exist. Furthermore, there was no evidence
of clustering of low load infections (LL), suggesting that high
load infections may be important in transmission of chlamy-
dial infection. There appears to be a threshold of C. trachoma-
tis load below which HH clustering (and being a HL outlier)
does not occur. The same phenomena were observed in data
including infected and uninfected individuals and data with
infected individuals only suggesting that low load infection
may represent a negligible risk of transmission. This supports
the described Allee effect, which hypothesises that a reduc-
tion in chlamydial fitness due to reduced pathogen population
size or density results in its disappearance from a population
(Chidambaram et al. 2005).
There are a limited number of studies that have assessed
the spatial distribution of trachoma (Polack et al. 2005; Clements
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Table 3. Multivariable mixed effects linear regression analysis of factors predictive of C. trachomatis load (omcB copies/swab) in infected
individuals.
Model Variable n ORa 95% CI P-Value AICb BICc loglikd
Nulle
884.8 894.3 –439.4
Clustering
Householdf 884.3 893.8 –439.1
Villagef 882.1 892.0 –438.2
Spatialg 799.7 834.8 –388.8
Finalh
Including age and disease severity
Spatial 802.6 844.1 –388.3
No spatial 797.7 829.6 –388.8
Age 0–5 years 87 2.60 0.99, 6.87 0.052
6–10 years 45 0.70 0.24, 2.05 0.509
11–15 years 15 1.77 0.43, 7.20 0.427
>15 years 37 1.00 – –
Disease severity Inflammatory grade (P)
0 46 1.00 – –
1 70 7.54 3.12, 18.20 <0.0001
2 46 22.8 8.15, 63.9 <0.0001
3 22 30.9 9.39, 101.50 <0.0001
Follicular grade (F)
0 91 1.00 – –
1 20 1.29 0.43, 3.84 0.649
2 27 2.20 0.82, 5.88 0.114
3 46 7.78 3.16, 19.15 <0.0001
Chlamydia trachomatis load is defined as log-(e) omcB copies/swab. There was no evidence of heteroscedasticity of residuals (Breusch-Pagan/Cook Weisberg test for
heteroscedasticity in the final model (χ2 = 0.44, P = 0.5079)).
aExponentiated coefficient.
bAIC = Akaike information criterion.
cBIC = Bayesian information criterion.
dloglik = Log likelihoood.
eNull model with dummy cluster variable.
fIncluding household or village as cluster variables on outcome.
gIncluding spatial structure.
hFinal model including covariates with and without adjustment for spatial structure.
et al. 2010; Smith et al. 2013) and ocular C. trachomatis infection
(Broman et al. 2006; Yohannan et al. 2014). Broman et al. (2006) did
not find clustering of active trachoma in children under the age
of 10 years, but found clusters of households with high bacterial
loads (defined as the household mean load) in treatment-naı¨ve
communities, supporting the findings in this study. Yohan-
nan et al. (2014) examined binary household-level data using a
K-function nearest neighbours analysis. The methodology for
cluster detection in these studies was heterogeneous, and mea-
sures of spatial dependence were not included in these analy-
ses.
This cross-sectional study is limited in the assumption of
load and clinical disease severity as a steady state. There are few
data addressing stability of C. trachomatis load and disease phe-
notype (Bobo et al. 1997). Bobo et al. (1997) conducted weekly sur-
veys for 3 months in hyperendemic communities, finding that
62% of children had at least one infection during that time and
of those 64% were persistently infected and had higher mean
C. trachomatis loads and more severe disease than those who
were sporadically infected. Additionally, host conjunctival im-
mune response and duration of infection add complexity to the
interaction between C. trachomatis infection and disease sever-
ity (Faal et al. 2006; Gambhir et al. 2009). Chlamydia trachomatis
strain diversity may also be associated with bacterial load, the
spectrum of disease severity and the clustering of high load in-
fections within these communities.
The role and importance of HH clusters and HL outliers in C.
trachomatis transmission is speculative, but their presence, and
the absence of low load clusters (LL) and low load outliers (LH),
suggests that C. trachomatis loadmay have a role in transmission,
and that these clustersmay represent a source for spread of ocu-
lar C. trachomatis infection. Studies in trachoma and C. trachoma-
tis infection in mouse models have suggested that C. trachomatis
load is associated with transmission (Pal et al. 1998; West et al.
2005). There is also some evidence from studies of urogenital
C. trachomatis infection in humans that individuals with asymp-
tomatic infection have lower C. trachomatis loads than individ-
uals with symptomatic infections (Wiggins et al. 2009) and that
the chance of sexual transmission of C. trachomatis per sexual
act may be influenced by load (Dirks et al. 2015). However, the
determinants of C. trachomatis load and its role in transmission
and the development of sequelae are not well understood (Vod-
strcil et al. 2014). Further longitudinal data in the context of tra-
choma endemicity andmass drug treatment are required to fully
address these questions and investigate the dynamics of C. tra-
chomatis load in transmission.
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Figure 4. Clusters and outliers of high load ocular C. trachomatis infections. Chlamydia trachomatis load log transformed (ln(ln+1)) due to significant negative skew.
Statistically significant positive values for the Local Moran’s I statistic indicate clustering with similarly high (H-H) or low (L-L) values. Negative values indicate that
neighbouring observations have dissimilar values and that this observation is an outlier (H-L or L-H). H-H clusters and H-L outliers are observed. There are no L-L
clusters. Observation values represent C. trachomatis load. Adjacency is defined by the zone of indifference.
CONCLUSION
This is the first study to use individual-level quantifiable Chlamy-
dia trachomatis infections from a geospatially representative
population-based sample to investigate spatial clustering of C.
trachomatis infection. These data show that increasing C. tra-
chomatis load is related to increasing disease severity in active
trachoma, particularly with respect to inflammation. We have
provided a global statistical measure for spatial autocorrelation
in infection and disease and used local indicators of spatial as-
sociation to describe the location and nature of the clusters in
relation to C. trachomatis load.
These data suggest that high load C. trachomatis infections
cluster spatially and may be important in transmission, al-
though further longitudinal study is required. Further epidemi-
ological and in vitro studies are required to provide a more com-
plete picture of the relationship between disease severity and
chlamydial load.
These geospatial tools may be useful as tools in trachoma
surveillance to identify clusters of infection and thresholds of
C. trachomatis bacterial load that may be important foci of trans-
mission. Using these methods in conjunction with novel molec-
ular tools to better define C. trachomatis strains and ‘virulence’
may also improve our understanding of C. trachomatis pathogen-
esis and transmission.
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